Halcyon is developing a device prototype that can not only separate the deteriorated cells and biowaste from healthy ones in stored blood but do so in quantities of blood that are useful for transfusions. The firm's current prototype is a plastic device, just a few inches in size. Two tubes - one that will feed blood into the device, and another that will push through saline solution - connect to the device. The companys work fits into a broader innovation trend related to other efforts in labs and companies to preserve the health of stored blood.
